Cyclodextrin Modified Block Polymer for Oral Chemotherapy
Journal of Pharmaceutical Research International,
Page 21-29
DOI:
10.9734/jpri/2020/v32i3831009
Abstract
Cationic polymers have received much attention for their potential use as nonviral gene delivery agents. Under certain conditions, these polymers self-assemble with poly(nucleic acids) via electrostatic interactions and condense them into submicron size particles that can be endocytosed by cells. Many drugs are commercially available for cancer treatment but most of them lacks in terms of poor solubility thereby resulting in inappropriate treatment. This research was planned and tested to ensure the preservation of product safety in our body for enhancing bioactivity of hybrid cyclodextrine nano-capsules, wherein cyclodextrin molecules are modified with Poly(e-Caprolactone)-Poly(Ethylene Glycol) (PCL-PEG), wherein nanocapsules were prepared from cyclodextrin and further were coated with PCL-PEG for enhancing cellular uptake and interacting with biological films in order to provide drug delivery of anti-cancer agent i.e. camptothecin. The nanocapsules were then further subjected to characterization studies which comprises zeta potential, drug release profiles, in-vitro toxicity and transfection effectiveness.
Keywords:
- Anti-cancer
- Cyclodextrin
- Nanocapsules
- Poly(e-Caprolactone)-Poly (Ethylene Glycol).
How to Cite
References
Thanki K, Gangwal RP, Sangamwar AT, Jain S. Oral delivery of anticancer drugs: Challenges and opportunities. Journal of Controlled Release; 2013. DOI: 10.1016/j.jconrel.2013.04.020.
Park TG, Jeong JH, Kim SW. Current status of polymeric gene delivery systems. Advanced Drug Delivery Reviews; 2006. DOI: 10.1016/j.addr.2006.03.007.
Zarepour A, Zarrabi A, Larsen KL. Fabricating Β-cyclodextrin based pH-responsive nanotheranostics as a programmable polymeric nanocapsule for simultaneous diagnosis and therapy. Int. J. Nanomedicine; 2019. DOI: 10.2147/IJN.S221598.
Newfang DA, Johnson GT, Harbison RD. Nanoparticles in Hamilton and Hardy’s Industrial Toxicology: Sixth Edition; 2015.
Khan I, Saeed K, Khan I, Nanoparticles: properties, applications and toxicities. Arabian Journal of Chemistry; 2019. DOI: 10.1016/j.arabjc.2017.05.011
Pun SH et al. Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjug Chem; 2004. DOI: 10.1021/bc049891g.
Ping Y, Liu C, Zhang Z, Liu KL, Chen J, Li J. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. Biomaterials; 2011. DOI: 10.1016/j.biomaterials.2011.07.038
Farah S, Anderson DG, Langer R. Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review. Advanced Drug Delivery Reviews. 2016. DOI: 10.1016/j.addr.2016.06.012
Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Advanced Drug Delivery Reviews; 2012. DOI: 10.1016/j.addr.2012.09.012
López-Jornet P, Camacho-Alonso F, Molina-Miñano F. Knowledge and attitudes about oral cancer among dentists in Spain. J Eval Clin Pract; 2010. DOI: 10.1111/j.1365-2753.2009.01132.x
Datta S, Chaturvedi P, Mishra A, Pawar P. A review of Indian literature for association of smokeless tobacco with malignant and premalignant diseases of head and neck region. Indian Journal of Cancer; 2014. DOI: 10.4103/0019-509X.146713
Weber AM, Ryan AJ, ATM and ATR as therapeutic targets in cancer. Pharma cology and Therapeutics; 2015. DOI: 10.1016/j.pharmthera.2014.12.001
Kantarjian HM, Talpaz M. Seminars in oncology, “clinical results in Philadelphia chromosome-positive leukemias; 2001.
Van Oosterom AT et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: A phase I study. Lancet; 2001. DOI: 10.1016/S0140-6736(01)06535-7
BJ et al. Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. Journal of Clinical Oncology; 2002.
Oncol RPSPASC. A phase II trial of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor OSI-774, following platinum-based chemotherapy, in patients with advancecd, EGFR-expressing, non-small cell lung cancer; 2001.
Boyd BJ et al. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. Eur J Pharm Sci; 2019. DOI: 10.1016/j.ejps.2019.104967.
Gan Y et al. Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization and enhanced cellular uptake. Int J Nanomedicine; 2011. DOI: 10.2147/ijn.s25741.
Moghadam Nazanin Soudbakhsh, Anil Kumar Hv, Muralidhar S. Talkad. Therapeutic potential of methanolic extract of evolvulus alsinoides plant for anti cancer activities in vitro. International Journal of Applied and Natural Sciences (IJANS) 2017;6(3):1-8.
Devi Meena. Synthesis And characterization of palladium nanoparticles & its contribution in photothermal therapy of cancer. International Journal of General Medicine and Pharmacy (IJGMP). 2019; 8(5):11–18.
Capek Ignác. Gold nanoparticles in cancer cell lines. International Journal of General Medicine and Pharmacy (IJGMP) Special Edition. 2016;1-14.
Bajwa Mohammad. Nanomedicine–The Futuristic medicine. International Journal of General Medicine and Pharmacy (IJGMP). 2016;6(1):1-8.
Naraghi, Laleh, Maryam Negahban. The application of nano technology in developing talaro myces flavus formulations. International Journal of Bio-Technology and Research (IJBTR). 2018; 8.(3):1-10.
Othayoth Rajath, Kalivarapu Sravya, Mah Endran Botlagunta. Nanophyto medicine and drug formulations. International Journal of Nanotechnology and Application (IJNA). 2014;4(3):1-8.
-
Abstract View: 356 times
PDF Download: 173 times
